Palvella Therapeutics (PVLA) Gains from Investment Securities (2014 - 2026)
Palvella Therapeutics (PVLA) reported Gains from Investment Securities of $3108.0 for Q1 2026, down 99.65% year-over-year from $892827.0 in Q1 2025, and down 99.89% on a QoQ basis from $2.9 million in Q4 2025.
Palvella Therapeutics (PVLA) has 13 years of Gains from Investment Securities data on file, last reported at $3108.0 in Q1 2026.
- Quarterly Gains from Investment Securities fell 99.65% year-over-year to $3108.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3108.0 (down 99.65% YoY) and the FY2025 annual result came in at $2.9 million, changed N/A from the prior year.
- Gains from Investment Securities retreated to $3108.0 in Q1 2026 per PVLA's latest filing, from $2.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.9 million in Q4 2025 and bottomed at -$214000.0 in Q2 2022.
- The 5-year median for Gains from Investment Securities is $33400.0 (2023), against an average of $500894.6.
- The widest annual swing landed in 2022, when Gains from Investment Securities slumped 421.95%; it then jumped 12935.72% in 2025.
- Tracing PVLA's Gains from Investment Securities over 5 years: stood at -$208000.0 in 2022, then soared by 63.46% to -$76000.0 in 2023, then soared by 538.35% to $333145.0 in 2024, then jumped by 775.64% to $2.9 million in 2025, then sank by 99.89% to $3108.0 in 2026.
- Per Business Quant, the three latest PVLA Gains from Investment Securities figures stand at $3108.0 (Q1 2026), $2.9 million (Q4 2025), and $47800.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,108.00 |
| Mar 31, 2026 | 3,108.00 |
| Dec 31, 2025 | 2.92 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 47,800.00 |
| Sep 30, 2025 | 47,800.00 |
| Jun 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 892,827.00 |
| Mar 31, 2025 | 892,827.00 |
| Sep 30, 2024 | 333,145.00 |
| Sep 30, 2024 | 333,145.00 |
| Jun 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Dec 31, 2023 | -76,000.00 |
| Dec 31, 2023 | -76,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | -72,000.00 |
| Mar 31, 2023 | -72,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Sep 30, 2022 | 513,000.00 |
| Sep 30, 2022 | 513,000.00 |
| Jun 30, 2022 | -214,000.00 |
| Jun 30, 2022 | -214,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Mar 31, 2021 | 41,000.00 |
| Mar 31, 2021 | 41,000.00 |
| Dec 31, 2020 | -764,000.00 |
| Dec 31, 2020 | -764,000.00 |
| Sep 30, 2020 | 636,000.00 |
| Sep 30, 2020 | 636,000.00 |
| Jun 30, 2020 | -243,000.00 |
| Jun 30, 2020 | -243,000.00 |
| Mar 31, 2020 | -100,000.00 |
| Mar 31, 2020 | -100,000.00 |
| Dec 31, 2019 | 1.25 Mn |
| Dec 31, 2019 | 1.25 Mn |
| Sep 30, 2019 | -241,000.00 |
| Sep 30, 2019 | -241,000.00 |
| Jun 30, 2019 | -147,000.00 |
| Jun 30, 2019 | -147,000.00 |
| Mar 31, 2019 | 298,000.00 |
| Mar 31, 2019 | 298,000.00 |
| Dec 31, 2018 | 1.28 Mn |
| Dec 31, 2018 | 1.28 Mn |
| Sep 30, 2018 | 430,000.00 |
| Sep 30, 2018 | 430,000.00 |
| Jun 30, 2018 | -46,000.00 |
| Jun 30, 2018 | -46,000.00 |
| Mar 31, 2018 | -8,000.00 |
| Mar 31, 2018 | -8,000.00 |
| Dec 31, 2017 | -206,000.00 |
| Dec 31, 2017 | -206,000.00 |
| Sep 30, 2017 | 1.95 Mn |
| Sep 30, 2017 | 1.95 Mn |
| Jun 30, 2017 | 1.26 Mn |
| Jun 30, 2017 | 1.26 Mn |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | 1.16 Mn |
| Dec 31, 2016 | 1.16 Mn |
| Dec 31, 2015 | 450,000.00 |
| Dec 31, 2015 | 450,000.00 |
| Sep 30, 2015 | 500,000.00 |
| Sep 30, 2015 | 500,000.00 |
| Jun 30, 2015 | 72,235.00 |
| Jun 30, 2015 | 72,235.00 |
| Mar 31, 2015 | 25,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Dec 31, 2014 | 2.52 Mn |
| Dec 31, 2014 | 2.52 Mn |
| Jun 30, 2014 | 18.00 |
| Jun 30, 2014 | 18.00 |
| Mar 31, 2014 | 18.00 |
| Mar 31, 2014 | 18.00 |